Patrick Campbell

Despite it being the preferred treatment in guidelines, ticagrelor was linked with more major bleeding and dyspnea than clopidogrel.

Approval of Aidoc's AI package could improve diagnosis and subsequent outcomes for stroke in emergency departments.

An expecting mother's use of antihypertensive medication may affect their risk of having a preterm birth, new findings show.

A recent analysis of participants in the NHANES database found low fat and Mediterranean diets were linked to lower serum testosterone levels in men.

An analysis of more than 9000 patients found incident heart disease was associated with an increased risk of developing kidney failure later in life.

A pilot study from the University of Warwick found sitagliptin, which is approved for glycemic control in diabetics, could be a promising treatment for reducing miscarriages in women with recurrent pregnancy loss.

Results of the Canadian CANTREAT study are debunking the notion anti-VEGF injections with ranibizumab need to take place monthly as opposed to a treat-and-extend regimen.

A new study has found habitual tea drinkers lowered their risk of atherosclerotic cardiovascular disease, coronary heart disease, and stroke compared to never or non-habitual tea drinkers.

An analysis of the CARDIA study revealed BMI in young adulthood served as a better predictor of obesity up to 25 years in the future than polygenic risk scores.

A recent study found a lower blood pressure target in older adults could reduce risk of cardiovascular events and death, but could negatively impact kidney function.

Abbot announced early Tuesday morning that the US FDA has granted approval for the HeartMate 3 device to be implanted via a lateral thoracotomy for patients with advanced heart failure.

A new study examining rates of venous thromboembolism revealed children receiving PICCs as opposed to CVCs were at an increased risk of blood clots.

The American College of Physicians has released guidelines, which include 4 new recommendations, for the treatment of age-related low testosterone in men.

A new study from George Mason University is offering additional insight into the impact of e-cigarette and combustible cigarette use on a person's risk of stroke.

A study from investigators at UCLA has identified a biomarker investigators suggest can help identify stable heart failure patients at an increased risk of death within the next 3 years.

Novo Nordisk announced the US FDA's approval of insulin aspart injection 100 u/mL (Fiasp) for glycemic control in children in a press release on Monday morning.

A recent study examining 140 Australians found alcohol abstinence reduced the recurrence and burden of atrial fibrillation in regular drinkers between the ages of 18 and 85 years old.

Increased levels of pyrethroid insecticide exposure was linked to increased in all-cause mortality, as well as increases in mortality from cancer and cardiovascular disease in a recent study from the University of Iowa.

The US Food and Drug Administration has announced a comprehensive ban on flavored, pod-based e-cigarette cartridges earlier this week.

A recent study from the Mayo Clinic of Rochester, MN is suggested diabetes mellitus is an independent risk factor for the development of heart failure.

TAVR has revolutionized treatment for aortic stenosis but we are still learning more about how to best manage antithrombotic strategy following this procedure.

A recent study from McMaster University has revealed NT-proBNP levels could serve as a predictor of cardiac injury after noncardiac procedures.

A decade of fine-tuning proven therapies and embracing advancing clinical technology has put ophthalmology in a rare space.

The US FDA has announced the approval of 2 applications for apixaban—marking the first generic approval of a direct oral anticoagulant.

Lumateperone (Caplyta), a novel therapy, has received approval from the US FDA for the treatment of schizophrenia in adults.

A study of TAVR and SAVR admissions over a 4-year period revealed 30-day mortality rates may be misrepresenting outcomes at 1 year.

A new study from Queen Mary University of London is revealing more about the potential impact of cannabis on cardiovascular health and function.

A new study published in Hypertension has found long work hours increased a person's risk for sustained and masked hypertension.

Results of the VESUVIUS trial are adding fuel to the fire in the debate over the impact of electronic cigarettes in former tobacco users.

A recent analysis from Tulane University has found a healthy sleep pattern could at least partially offset risk of stroke or cardiovascular disease in patients with a high genetic risk.